harrison.ai raises AUD$129 million and partners with Sonic Healthcare to develop pathology AI, accelerating its mission to expand capacity of global healthcare
Summary
The funding will go to helping harrison.ai expand on its mission to scale critical capacity in the global healthcare system through rapid commercialisation of comprehensive clinical AI applications. harrison.ai also announced a new partnership with Sonic Healthcare (ASX:SHL), a leader in medical diagnostics, to co-develop and commercialise new clinical AI solutions in pathology. This increased demand for equitable, accurate and effective healthcare delivery requires complementary systems like Artificial Intelligence (AI) to provide human-aided diagnosis and help relieve some of this disparity. It will combine Harrison.ai’s depth of expertise with Sonic Healthcare’s clinical experience and distribution to commercialise an effective and accurate AI solution in pathology rapidly. “Sonic Healthcare’s deep clinical experience and understanding combined with our proven AI methodologies will create a powerful new way to support clinicians to more effectively and efficiently diagnose patients in pathology,” Dr Tran said.